If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Another example of crooked aim mms doing their best to present an alternative to confident buying so they get cheap shares for next leg up
If we officially partner with the other massive mri Company without exclusivity we are going to be in the pounds not pennies
Yes and he will have seen some tech in his time and him being convinced it will become a standard add on tech is an amazing statement and confirmation that leads me to believe that this could be the final part of the funding collaboration partnership
Https://www.linkedin.com/posts/timo-schirmer-a39b3625_xenonmri-ismrm2024-mritechnology-activity-7194692763882295296-J4VL?utm_source=share&utm_medium=member_android
We got every global mri manufacturer eating out of our hands. This is kind of saying yep we're a customer and looking forward to integrating the tech in future projects. Fantastic
Nice volume steady rise today I'd say, think with what we have Sales wise we should be between 5-10p . Next deal will see us over 10p again.
Won't be long. The tech and cvj and bastiaan have every faith in.
The next system purchase rns. Just another of many advocates
I agree slick. Duke to come and now the 2 de novos shows it wasn't one off interest. De novos will now grow imo and take over triallists.
It's finally happening. Funding through a partnership I think for gas exchange I think highly likely.
This is finally happening against all the noise about survival etc some of us have kept the light shining and now people we are on our way. British bulls are on buy now after 2 months short. I think there subscriber's have a big impact on sp in quiet times.
Let's hope for another tip somewhere soon, and keep the system take up going.
I know cincinatti are performing a lot of scans including a number of 6-12 year old age group on track with the fda for range expansion. Which will be another doubling. The gas exchange another doubling.
Duke on its way. But might have others before.
I'm excited.... and relieved my convictions were correct.
Credit advfn thread
The bull case FWIW.
Stifel reiterated its #Buy rating & its target price of :43p (current price: 4p) #POLX
We see encouraging evidence of building commercial interest in #Xenoview....we believe delivery on commercial targets for 2024/25 has the potential to significantly re-rate the shares from current lows
https://www.voxmarkets.co.uk/articles/polarean-imaging-shares-soar-on-second-de-novo-order-for-xenoview-70839d1/
You could more than likely be buying back in double figures after financial news. But maybe don't to hold for a few hours. We've just hit 2024 targets by early May. So anything additional which there is plenty to come will see us over shooting the market by far. And way newslow is going at the moment we may have something 7am Monday and you won't be publicly bragging your prowess then
Ie people who appreciate the unfolding story here and the tech and know where its going rather than just a simple shallow trader.
I don't think anyone cares what you did. You came and went with the parasites the wise wait for the recoveries full bloom and the anticipated further newsflow. Gla lth and those that managed to hold for the day.
Omg we been cluttered by pathetic p ricks. Oh I guess being top of gainers boards bring them out. Wow the parasites
Polarean shares soar on University of Alabama deal for Xenon MRI
Fri, 10th May 2024 11:40Alliance News
(Alliance News) - Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital in the US.
Shares in Polarean were up 37% at 4.72 pence each in London on Friday morning.
Nice margin. And the razor and blades business model. Plenty ongoing through gas supply and support after initial large purchase monies
Thats the 4th firm full system purchase, 15 triallists very hot leads to convert. Convert they will.
Well on track for this year's targets.
Buggers pulled the trade at 3.85 and went negotiated ... grrrr so looks like 4p top up
On top of the trialists. This is the sign of the surge upwards to never look back. Well done holders who didn't papp themselves.
Polarean Imaging plc
("Polarean" or the "Company")
New Xenon MRI System order received
Top-tier academic hospital becomes the first de novo site in the southeast U.S
Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of lung function, announces that it has received its second de novo order for a new Xenon MRI System from the University of Alabama at Birmingham ("UAB") Hospital, a top-tier academic hospital in the south-eastern region of the U.S. The 'de novo' designation indicates that UAB Hospital is acquiring this innovative imaging technology for the first time, without a prior research programme utilising the Polarean Xenon MRI System. This milestone underscores the increasing adoption and impact of Polarean's cutting-edge MRI solutions.
The Company expects to install the new system later this year and will collaborate closely with the hospital team, as it does with its existing clinical sites, to develop a strong Xenon MRI programme. This programme will support clinical imaging, NIH-funded research, and pharmaceutical-sponsored trials, aligning with Polarean's commitment to advancing medical research and patient care.
Christopher R. von Jako, Ph.D., CEO of Polarean, said: "Expanding our user base is one of the five key growth pillars we identified last year, and so I am delighted to have received our second de novo system order from UAB Hospital, a prestigious top-tier U.S. academic facility. Hospital acquisition of new capital equipment can be a lengthy process, and so momentum continues to build for our sales success. Contingent on the installation of this polariser system, and the two additional previously announced system orders, during 2024, the Company has completed sales and firm orders as of today that would result in 2024 revenue of approximately $2.5M. We expect additional orders to come in this year that will result in additional 2024 revenue. We are very excited to see that our commercial growth strategy is yielding tangible results."
Alex Dusek, Chief Commercial Officer of Polarean, said: "Feedback on the Polarean technology from physicians continues to be overwhelmingly positive, and we look forward to working closely with clinicians and scientists at UAB hospital to help establish the approved use of XENOVIEW™ for the visualisation of ventilation patients aged 12 and older. We are continuing to have productive meetings with our other high-priority centres, as they work through the necessary steps of the value assessment and procurement process. These centres are becoming increasingly aware of our technology's clinical, scientific, and economic value in lung ventilation, as well as research into gas exchange and cardiopulmonary for future applications, where we recently strengthe
Thanks slick. Fantastic. Nukem and Philips and noticed increased interaction with GE. Also we have lots of synergys connections with medtronic. There's some irons in the fire. ;)